These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20947663)

  • 1. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome.
    Kerckhoffs APM; Ben-Amor K; Samsom M; van der Rest ME; de Vogel J; Knol J; Akkermans LMA
    J Med Microbiol; 2011 Feb; 60(Pt 2):236-245. PubMed ID: 20947663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.
    Maukonen J; Satokari R; Mättö J; Söderlund H; Mattila-Sandholm T; Saarela M
    J Med Microbiol; 2006 May; 55(Pt 5):625-633. PubMed ID: 16585652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.
    Noor SO; Ridgway K; Scovell L; Kemsley EK; Lund EK; Jamieson C; Johnson IT; Narbad A
    BMC Gastroenterol; 2010 Nov; 10():134. PubMed ID: 21073731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
    Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
    World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.
    Mättö J; Maunuksela L; Kajander K; Palva A; Korpela R; Kassinen A; Saarela M
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):213-22. PubMed ID: 15747442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.
    Giamarellos-Bourboulis E; Tang J; Pyleris E; Pistiki A; Barbatzas C; Brown J; Lee CC; Harkins TT; Kim G; Weitsman S; Barlow GM; Funari VA; Pimentel M
    Scand J Gastroenterol; 2015; 50(9):1076-87. PubMed ID: 25865706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients.
    Kerckhoffs AP; Samsom M; van der Rest ME; de Vogel J; Knol J; Ben-Amor K; Akkermans LM
    World J Gastroenterol; 2009 Jun; 15(23):2887-92. PubMed ID: 19533811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.
    Rangel I; Sundin J; Fuentes S; Repsilber D; de Vos WM; Brummer RJ
    Aliment Pharmacol Ther; 2015 Nov; 42(10):1211-21. PubMed ID: 26376728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
    Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
    Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial community and metabolomic comparison of irritable bowel syndrome faeces.
    Ponnusamy K; Choi JN; Kim J; Lee SY; Lee CH
    J Med Microbiol; 2011 Jun; 60(Pt 6):817-827. PubMed ID: 21330412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.
    Nagel R; Traub RJ; Allcock RJ; Kwan MM; Bielefeldt-Ohmann H
    Microbiome; 2016 Aug; 4(1):47. PubMed ID: 27580855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.
    Chung CS; Chang PF; Liao CH; Lee TH; Chen Y; Lee YC; Wu MS; Wang HP; Ni YH
    Scand J Gastroenterol; 2016; 51(4):410-9. PubMed ID: 26595305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
    Krogius-Kurikka L; Lyra A; Malinen E; Aarnikunnas J; Tuimala J; Paulin L; Mäkivuokko H; Kajander K; Palva A
    BMC Gastroenterol; 2009 Dec; 9():95. PubMed ID: 20015409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.
    Codling C; O'Mahony L; Shanahan F; Quigley EM; Marchesi JR
    Dig Dis Sci; 2010 Feb; 55(2):392-7. PubMed ID: 19693670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
    Kassinen A; Krogius-Kurikka L; Mäkivuokko H; Rinttilä T; Paulin L; Corander J; Malinen E; Apajalahti J; Palva A
    Gastroenterology; 2007 Jul; 133(1):24-33. PubMed ID: 17631127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.